Format
Items per page
Sort by

Send to:

Choose Destination

Results: 8

Related Articles by Review for PubMed (Select 15705864)

1.

p300 modulates nuclear morphology in prostate cancer.

Debes JD, Sebo TJ, Heemers HV, Kipp BR, Haugen DL, Lohse CM, Tindall DJ.

Cancer Res. 2005 Feb 1;65(3):708-12.

2.

Nuclear matrix proteins as biomarkers in prostate cancer.

Leman ES, Getzenberg RH.

J Cell Biochem. 2002;86(2):213-23. Review.

PMID:
12111991
3.

Quantitative nuclear grade (QNG): a new image analysis-based biomarker of clinically relevant nuclear structure alterations.

Veltri RW, Partin AW, Miller MC.

J Cell Biochem Suppl. 2000;Suppl 35:151-7. Review.

PMID:
11389545
4.

Nuclear morphometry, nucleomics and prostate cancer progression.

Veltri RW, Christudass CS, Isharwal S.

Asian J Androl. 2012 May;14(3):375-84. doi: 10.1038/aja.2011.148. Epub 2012 Apr 16. Review.

5.

Nuclear matrix proteins as cancer markers.

Davido T, Getzenberg RH.

J Cell Biochem Suppl. 2000;Suppl 35:136-41. Review.

PMID:
11389543
6.

TRPV6 and prostate cancer: cancer growth beyond the prostate correlates with increased TRPV6 Ca2+ channel expression.

Wissenbach U, Niemeyer B, Himmerkus N, Fixemer T, Bonkhoff H, Flockerzi V.

Biochem Biophys Res Commun. 2004 Oct 1;322(4):1359-63. Review.

PMID:
15336984
7.

Nuclear structural proteins as biomarkers of cancer.

Konety BR, Getzenberg RH.

J Cell Biochem. 1999;Suppl 32-33:183-91. Review.

PMID:
10629118
8.

The nuclear matrix in pathology.

Bosman FT.

Virchows Arch. 1999 Oct;435(4):391-9. Review.

PMID:
10526002
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk